Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/QAI.0b013e318256f3bcPMID 22569268PMCID PMC3383928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma sCD14 Is a Biomarker Associated With Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection

  2011cited by this paper
• Acceleration of HIV dementia with methamphetamine and cocaine

  2011cited by this paper
• Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals

  2011cited by this paper
• HIV-associated cognitive impairment before and after the advent of combination therapy

  2011cited by this paper
• Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

  2011cited by this paper
• CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection

  2011cited by this paper
• Hepatitis C infection, Cognition, and inflammation in an Egyptian sample

  2011cited by this paper
• HIV-associated neurocognitive disorders: is there a hidden epidemic?

  2010cited by this paper
• Food combination and Alzheimer disease risk: a protective diet.

  2010cited by this paper
• Neurologic complications of HIV disease and their treatment.

  2010cited by this paper
• Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

  2010cited by this paper
• Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

  2010cited by this paper
• Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap

  2010cited by this paper
• MetaboAnalyst: a web server for metabolomic data analysis and interpretation

  2009cited by this paper
• Drug Abuse and Hepatitis C Infection as Comorbid Features of HIV Associated Neurocognitive Disorder: Neurocognitive and Neuroimaging Features

  2009cited by this paper
• Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients

  2008cited by this paper
• Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

  2008cited by this paper
• Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy

  2008cited by this paper
• Biomarkers of HIV related central nervous system disease

  2008cited by this paper
• Antiretroviral Treatment Effect on Immune Activation Reduces Cerebrospinal Fluid HIV-1 Infection

  2008cited by this paper
• Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy

  2008cited by this paper
• Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.

  2007cited by this paper
• Updated research nosology for HIV-associated neurocognitive disorders

  2007cited by this paper
• Neuroimmunity, Drugs of Abuse, and neuroAIDS

  2006cited by this paper
• Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.

  2006cited by this paper
• HIV-1 infection and AIDS: consequences for the central nervous system

  2005cited by this paper
• Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort

  2005cited by this paper
• Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection

  2005cited by this paper
• The neuropathogenesis of AIDS

  2005cited by this paper
• Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.

  2005cited by this paper
• Undetectable Cerebrospinal Fluid HIV RNA and β-2 Microglobulin Do Not Indicate Inactive AIDS Dementia Complex in Highly Active Antiretroviral Therapy-Treated Patients

  2005cited by this paper
• Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

  2004cited by this paper
• Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV

  2004cited by this paper
• Antiretroviral Treatment Alters Relationship between Mcp-1 and Neurometabolites in HIV Patients

  2003cited by this paper
• Insights into the role of immune activation in HIV neuropathogenesis

  2002cited by this paper
• Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.

  2001cited by this paper
• Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

  2001cited by this paper
• Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application

  2001cited by this paper
• Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.

  2000cited by this paper
• Cerebrospinal fluid β2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor α receptors before and after treatment with lamivudine plus zidovudine or stavudine

  2000cited by this paper
• Increasing Cerebrospinal Fluid Chemokine Concentrations Despite Undetectable Cerebrospinal Fluid HIV RNA in HIV‐1‐Infected Patients Receiving Antiretroviral Therapy

  2000cited by this paper
• Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1

  1999cited by this paper
• Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.

  1999cited by this paper
• Chemokines and receptors in HIV encephalitis

  1998cited by this paper
• Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.

  1998cited by this paper
• β‐Chemokines MCP‐1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus–associated dementia

  1998cited by this paper
• Elevated cerebrospinal fluid levels of monocyte chemotactic protein‐1 correlate with HIV‐1 encephalitis and local viral replication

  1998cited by this paper
• Haptoglobin polymorphism, iron metabolism and mortality in HIV infection

  1998cited by this paper
• Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.

  1997cited by this paper
• Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

  1997cited by this paper
• Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

  1997cited by this paper
• Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.

  1996cited by this paper
• Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

  1993cited by this paper
• Increased Neopterin Levels in Brains of Patients with Human Immunodeficiency Virus Type 1 Infection

  1992cited by this paper
• Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis

  1992cited by this paper
• Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection.

  1992cited by this paper
• Neopterin and interferon‐gamma in serum and cerebrospinal fluid of patients with HIV‐associated neurologic disease

  1991cited by this paper
• Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection

  1990cited by this paper
• Open Access Review Molecular Mechanisms of Neuroinvasion by Monocytes-macrophages in Hiv-1 Infection

  year unknowncited by this paper

• Implications and prospects of immunological and neuroimaging research in HIV-associated neurocognitive disorders.

  2026cites this paper
• Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches

  2025cites this paper
• Plasma Inflammatory Biomarkers Link to Worse Cognition Among Africans with HIV.

  2025cites this paper
• Multifaceted Role of Nef in HIV-Associated Neurocognitive Disorder: Histopathological Alterations and Underlying Mechanisms

  2025cites this paper
• Multiplexing Proteomic and Ingenuity Pathway Analysis of Attention/Working Memory in Virally Suppressed Women with HIV: A Feasibility Study

  2025cites this paper
• Treatment in acute HIV infection only temporarily preserves monocyte function: a comparative cohort study in adult males

  2025cites this paper
• Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIV

  2025cites this paper
• HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives

  2025cites this paper
• CD8+T cells and monocytes were associated with brain alterations in human immunodeficiency virus-infected individuals with cognitive impairment.

  2025cites this paper
• Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review

  2024cites this paper
• CD14+CD16+ monocyte transmigration across the blood-brain barrier is associated with HIV-NCI despite viral suppression

  2024cites this paper
• Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection

  2024cites this paper
• Inflammation biomarkers and neurobehavioral performance in rural adolescents

  2024cites this paper
• Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

  2024cites this paper
• Nef mediates neuroimmune response, myelin impairment, and neuronal injury in EcoHIV-infected mice

  2024cites this paper
• Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications

  2024cites this paper
• The relationship between HIV‐1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post‐mortem brain tissue

  2024cites this paper
• Age-associated dementia among older people aging with HIV in the United States: a modeling study

  2024cites this paper
• Probing bundle-wise abnormalities in patients infected with human immunodeficiency virus using fixel-based analysis: new insights into neurocognitive impairments

  2023cites this paper
• Intrathecal production of anti-Epstein–Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV

  2023cites this paper
• CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy

  2023cites this paper
• Pillars of long-term antiretroviral therapy success.

  2023cites this paper
• Persistent Inflammation and Non-AIDS Comorbidities During ART: Coming of the Age of Monocytes

  2022cites this paper
• Soluble CD14 is subtype-dependent in serum but not in cerebrospinal fluid in people with HIV.

  2022cites this paper
• Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation

  2022cites this paper
• Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection

  2022cites this paper
• Application of Diffusion Tensor Imaging (DTI) in the Diagnosis of HIV-Associated Neurocognitive Disorder (HAND): A Meta-Analysis and a System Review

  2022cites this paper
• Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders

  2022cites this paper
• Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI

  2022cites this paper
• Microglial/macrophage activation in the cerebrospinal fluid of neuromyelitis optica spectrum disorders

  2022cites this paper
• Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

  2021cites this paper
• Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era

  2021cites this paper
• Plasma Cytokine Levels As Predictors of Global and Domain-Specific Human Immunodeficiency Virus-Associated Neurocognitive Impairment in Treatment-Naive Individuals

  2021cites this paper
• Advances in the Experimental Models of HIV-Associated Neurological Disorders

  2021cites this paper
• Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV

  2021cites this paper
• Role of Brain Arterial Remodeling in HIV-Associated Cerebrovascular Outcomes

  2021cites this paper
• Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review.

  2021cites this paper
• Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV

  2021cites this paper
• Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120

  2021cites this paper
• Cerebrovascular Contributions to Neurocognitive Disorders in People Living With HIV

  2021cites this paper
• Immune Dysregulation Is Associated with Neurodevelopment and Neurocognitive Performance in HIV Pediatric Populations—A Scoping Review

  2021cites this paper
• Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era

  2021cites this paper
• Cannabis and Inflammation in HIV: A Review of Human and Animal Studies

  2021cites this paper
• Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities

  2021cites this paper
• Co-receptor signaling in the pathogenesis of neuroHIV

  2021cites this paper
• Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders

  2020cites this paper
• The association of peripheral immune markers with brain cortical thickness and surface area in South African people living with HIV

  2020influential citation
• New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment.

  2020cites this paper
• Cadmium induces CCL2 production in glioblastoma cells via activation of MAPK, PI3K, and PKC pathways

  2020cites this paper
• Cerebrospinal Fluid Microglial Activation Markers in Patients With Neuromyelitis Optica

  2020cites this paper
• Negative regulation of IL-8 in human astrocytes depends on β-catenin while positive regulation is mediated by TCFs/LEF/ATF2 interaction.

  2020cites this paper
• CSF biomarkers as potential screen of HIV-1 subtype C in post-HAART era

  2020cites this paper
• Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naïve Individuals in Nigeria.

  2020cites this paper
• Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies.

  2020cites this paper
• Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder

  2020influential citation
• Comparison of [11C]-PBR28 binding between persons living with HIV and HIV uninfected individuals.

  2020cites this paper
• HIV-Associated Neurocognitive Disorder (HAND)

  2020cites this paper
• Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairment

  2020cites this paper
• Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.

  2020cites this paper
• Blue Monday: Co-Occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.

  2020cites this paper
• Peripheral immune dysregulation in the ART era of HIV-associated neurocognitive impairments: A systematic review.

  2020cites this paper
• Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

  2019cites this paper
• Olive Oil Intake Associated with Increased Attention Scores in Women Living with HIV: Findings from the Chicago Women’s Interagency HIV Study

  2019cites this paper
• The Association of Immune Markers with Cognitive Performance in South African HIV-Positive Patients

  2019cites this paper
• The role of catecholamines in HIV neuropathogenesis.

  2019cites this paper
• High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children

  2019cites this paper
• Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda

  2019cites this paper
• Δ9-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7–Stimulated Human Coculture

  2019cites this paper
• Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders

  2019cites this paper
• Systemic and intrathecal immune activation in association with cerebral and cognitive outcomes in paediatric HIV

  2019cites this paper
• HIV‐1 Tat promotes astrocytic release of CCL2 through MMP/PAR‐1 signaling

  2019cites this paper
• Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment

  2019cites this paper
• The influence of single nucleotide polymorphisms and epigenetics on HIV disease progression

  2019cites this paper
• Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals

  2019cites this paper
• Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities

  2019cites this paper
• Neurocognitive Complications of Pediatric HIV Infections.

  2019cites this paper
• Csf Lymphocyte And Monocyte Activation And Trafficking In Primary Hiv Infection

  2019cites this paper
• Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder

  2019cites this paper
• Inflammatory Mechanisms and Cascades Contributing to Neurocognitive Impairment in HIV/AIDS.

  2019cites this paper
• Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis

  2019cites this paper
• Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy

  2018cites this paper
• Lymphocyte-Dominant Encephalitis and Meningitis in Simian Immunodeficiency Virus-Infected Macaques Receiving Antiretroviral Therapy.

  2018cites this paper
• Human Immunodeficiency Virus and the Nervous System.

  2018cites this paper
• Soluble CD14, CD163, and CD27 biomarkers distinguish ART‐suppressed youth living with HIV from healthy controls

  2018cites this paper
• CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?

  2018cites this paper
• Frontline Science: Buprenorphine decreases CCL2‐mediated migration of CD14+CD16+ monocytes

  2018cites this paper
• Relationship Between Brain Arterial Pathology and Neurocognitive Performance Among Individuals With Human Immunodeficiency Virus

  2018cites this paper
• Fractures and the gut microbiome

  2018cites this paper
• Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection

  2017cites this paper
• Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders

  2017cites this paper
• Informatic Interrogation of CSF Proteomic Profiles from HIV-Infected Subjects Implicates Acute Phase and Complement Systems in Shifting Cognitive Status

  2017cites this paper
• Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation

  2017cites this paper
• Degradation of heme oxygenase‐1 by the immunoproteasome in astrocytes: A potential interferon‐γ‐dependent mechanism contributing to HIV neuropathogenesis

  2017cites this paper
• Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity

  2017cites this paper
• HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis

  2017cites this paper
• Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children 03

  2017cites this paper
• When do models of NeuroAIDS faithfully imitate “the real thing”?

  2017cites this paper
• HIV-Tat regulates macrophage gene expression in the context of neuroAIDS

  2017cites this paper
• High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid

  2017cites this paper
• Frontline Science: CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS

  2017cites this paper